Karyopharm Therapeutics Inc. (KPTI)
NASDAQ · Healthcare
Karyopharm Therapeutics Inc. Shareholder Equity 2011–2025
Karyopharm Therapeutics Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Karyopharm Therapeutics Inc. shareholder equity as of December 31, 2025: -292.9M, a 57.47% increase year-over-year.
- Karyopharm Therapeutics Inc. shareholder equity for 2025 were -292.9M, a 57.47% increase from 2024.
- Karyopharm Therapeutics Inc. shareholder equity for 2024 were -186.0M, a 36.57% increase from 2023.
- Karyopharm Therapeutics Inc. shareholder equity for 2023 were -136.2M, a 717.76% increase from 2022.
- Karyopharm Therapeutics Inc. shareholder equity for 2022 were -16.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Karyopharm Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-293 |
| 2024 | $-186 |
| 2023 | $-136 |
| 2022 | $-17 |
| 2021 | $-80 |
| 2020 | $51 |
| 2019 | $50 |
| 2018 | $183 |
| 2017 | $129 |
| 2016 | $162 |
| 2015 | $198 |
| 2014 | $207 |
| 2013 | $155 |
| 2012 | $-28 |
Karyopharm Therapeutics Inc. Shareholder Equity — FAQ
Karyopharm Therapeutics Inc. (KPTI) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KPTI's shareholder equity history?
The chart and table above show Karyopharm Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.